
Actin filaments are fundamental components of the cytoskeleton, essential for maintaining cell shape, enabling motility, and facilitating intracellular transport. Cryo-electron tomography (cryo-ET) enables nanometer-resolution visualization of filament networks in situ; however, low signal-to-noise ratios, missing wedge artifacts, and complex 3D architectures present significant challenges for accurate analysis. Manual filament annotation is highly resource-intensive and prone to variability, underscoring the need for automated approaches. In this study, we develop and evaluate deep learning-based semantic segmentation architectures for accurate segmentation of actin filament networks in cryo-ET data. We systematically assess several architectures-3D U-Net, Attention 3D U-Net, TransUNet 3D, and UNETR-on simulated tomograms with known ground truth. Model performance is quantified using Dice scores and Intersection over Union (IoU) to evaluate segmentation performance under challenging imaging conditions. Our results show that no single deep learning architecture consistently outperforms others, highlighting the importance of accounting for filament arrangement and noise characteristics. By providing a comparative evaluation of these architectures, we demonstrate their effectiveness in detecting filamentous structures and offer guidance for future efforts to improve segmentation performance.
Gut microbiome-based disease diagnosis holds significant promise but remains challenging due to the high data dimensionality, typically small sample sizes, and the necessity of incorporating biological knowledge. Due to these challenges, traditional machine learning approaches often tend to overfit the data and fail to capture true biological relationships, resulting in inaccurate diagnoses. To fill in the gap, we propose a two-phase, knowledge-guided large language model (LLM) framework for disease diagnosis that integrates biomedical expertise with in-context learning. In Phase 1, an LLM is employed to identify disease-associated taxa from hundreds of microbial families and to infer their biological relationships with the disease outcome. This process reduces the feature space dimensionality through biologically-informed feature selection and acquires essential domain knowledge. In Phase 2, we employ few-shot prompting to guide the LLM in disease outcome classification based on the domain knowledge acquired in Phase 1. Thanks to the universal applicability of LLM and our two-phase approach, this is a generic framework that can be applied to a wide range of microbiome-based disease diagnostic tasks. We demonstrate the superiority of our framework using inflammatory bowel disease (IBD) as a representative case study, where our approach achieves an accuracy of 73.91%, significantly outperforming an optimized XGBoost classifier. Overall, our knowledge-guided framework provides a powerful and generalizable strategy for leveraging LLMs in microbiome-based disease diagnosis, and opens a new avenue for disease diagnosis in the era of LLM.
With the growing prevalence of cognitive impairment, early detection has become increasingly critical. Prior studies have examined the association between neuropsychiatric symptoms (NPS) and cognitive impairment, identifying potential predictive relationships. However, they hardly evaluated the heterogeneous relationships between serial patterns of NPS and evolving cognition status of the patients. To address this limitation, we investigate the statistical causal relationship between NPS and cognitive impairment, as well as the dynamic changes in their predictive effects over time, with a specific focus on sex differences. Our approach accounts for the fluctuating nature of NPS and varying follow-up durations across participants by implementing a bootstrap strategy that repeatedly samples a fixed number of visits per participant in a temporal order. Then, we apply causal discovery techniques and counterfactual framework-based causal inference methods to estimate the independent effects of NPS over time. Our findings highlight apathy as a key predictive symptom of cognitive impairment. Moreover, its predictive effect peaks earlier in females than in males, indicating that early-stage tracking is particularly informative in female participants. This suggests sex-specific monitoring strategies may improve early detection and intervention of cognitive impairment.
Accurately modeling the binding between T-cell receptors (TCRs) and peptide-MHC (pMHC) complexes is essential for guiding immunotherapy development and personalized vaccine design. However, the vast diversity of TCR repertoires and the scarcity of experimentally validated interactions make generalization to unseen epitopes challenging. This paper proposes TIDE, a cross-attention-driven dual-encoder framework that leverages large protein and molecular language models to learn discriminative representations of TCRs and peptides. In TIDE, TCR sequences are encoded using Evolutionary Scale Modeling (ESM), while peptides are transformed into SMILES strings and processed by MolFormer to capture chemical and structural properties. Multi-layer cross-attention then refines and integrates these embeddings, highlighting interaction-relevant patterns without requiring explicit structural alignment. Evaluated on the TCHard benchmark under both zero-shot and few-shot settings, TIDE achieves superior predictive accuracy and robustness compared to state-of-the-art baselines such as ChemBERTa, TITAN, and NetTCR. These results demonstrate that combining pretrained language models with cross-attention fusion offers a powerful approach for TCR-pMHC binding prediction and paves the way for more reliable computational immunology applications.
Integrating novel medical concepts and relationships into existing ontologies can significantly enhance their coverage and utility for both biomedical research and clinical applications. Clinical notes, as unstructured documents rich with detailed patient observations, offer valuable context-specific insights and represent a promising yet underutilized source for ontology extension. Despite this potential, directly leveraging clinical notes for ontology extension remains largely unexplored. To address this gap, we propose CLOZE, a novel framework that uses large language models (LLMs) to automatically extract medical entities from clinical notes and integrate them into hierarchical medical ontologies. By capitalizing on the strong language understanding and extensive biomedical knowledge of pre-trained LLMs, CLOZE effectively identifies disease-related concepts and captures complex hierarchical relationships. The zero-shot framework requires no additional training or labeled data, making it a cost-efficient solution. Furthermore, CLOZE ensures patient privacy through automated removal of protected health information (PHI). Experimental results demonstrate that CLOZE provides an accurate, scalable, and privacy-preserving ontology extension framework, with strong potential to support a wide range of downstream applications in biomedical research and clinical informatics.